TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) has shared an announcement.
Giant Biogene Holding Co., Ltd has announced its intention to repurchase up to 103,590,400 shares, representing 10% of its issued shares, under a Share Repurchase Mandate approved by shareholders. This move, financed by the company’s own funds, aims to reflect the board’s confidence in the company’s long-term strategy and growth, improve financial indicators like earnings per share, and optimize capital structure. The repurchase will be subject to compliance with relevant regulations, and its implementation will depend on market conditions and the board’s discretion.
The most recent analyst rating on (HK:2367) stock is a Buy with a HK$70.00 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and providing biotechnological products and services, with a market emphasis on enhancing shareholder value and optimizing capital structure.
Average Trading Volume: 12,540,626
Technical Sentiment Signal: Hold
Current Market Cap: HK$38.26B
Learn more about 2367 stock on TipRanks’ Stock Analysis page.